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Available online 24 June 2013Abstract Human embryonic stem cells (hESCs) are emerging as an attractive alternative source for cell replacement therapy
since the cells can be expanded in culture indefinitely and differentiated into any cell types in the body. In order to optimize
cell-to-cell interaction, cell proliferation and differentiation into specific lineages as well as tissue organization, it is important
to provide a microenvironment for the hESCs which mimics the stem cell niche. One approach is to provide a three-dimensional
(3D) environment such as encapsulation. We present an approach to culture and differentiate hESCs into midbrain dopamine
(mdDA) neurons in a 3D microenvironment using alginate microcapsules for the first time. A detailed gene and protein
expression analysis during neuronal differentiation showed an increased gene and protein expression of various specific DA
neuronal markers, particularly tyrosine hydroxylase (TH) by N100 folds after 2 weeks and at least 50% higher expression after
4 weeks respectively, compared to cells differentiated under conventional two-dimensional (2D) platform. The encapsulated
TH+ cells co-expressed mdDA neuronal markers, forkhead box protein A-2 (FOXA2) and pituitary homeobox-3 (PITX3) after
4 weeks and secreted approximately 60 pg/ml/106 cells higher DA level when induced. We propose that the 3D platform
facilitated an early onset of DA neuronal generation compared to that with conventional 2D system which also secretes more DA
under potassium-induction. It is a very useful model to study the proliferation and directed differentiation of hESCs to various
lineages, particularly to mdDA neurons. This 3D system also allows the separation of feeder cells from hESCs during the process
of differentiation and also has potential for immune-isolation during transplantation studies.
© 2013 Elsevier B.V. All rights reserved.Introduction
One of the foremost causes of human ailment late in life is
neurodegenerative disease. PD is a prominent type of such
disease, which presents with various motor and mental
disabilities, and affects 1% of the human population above⁎ Corresponding author at: Stem Cell Lab, G65 Lvl 2 Clinical Science
Bld, Prince of Wales Hospital, High St., Randwick, NSW 2031, Australia.
E-mail address: jaeminkim85@hotmail.com (J. Kim).
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http://dx.doi.org/10.1016/j.scr.2013.06.005the age of 65 (Chiba et al., 2008). The main pathological
cause of PD is the progressive degeneration of DA neurons
which reside in the midbrain substantia nigra (SN) and
project their axons to the basal ganglia striatum (Ma et al.,
2011; Jiang et al., 2012; Hardy, 2010). Although many
pharmacological and surgical treatments for PD are currently
available, none provides a cure and all have risks of side
effects (Cai et al., 2009; Snyder and Olanow, 2005). Hence,
there has been extensive research in the field of DA neuron
regenerative medicine as an alternative treatment for PD,
with the focus being on stem cells (Cai et al., 2009; Jaderstad
et al., 2010; Zhou et al., 2010).
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can proliferate indefinitely in an undifferentiated state in
vitro, are arguably the most suitable cell source for develop-
ing cell replacement therapy for PD. Many studies have
demonstrated differentiation of hESCs to DA neurons in vitro
and in vivo via various strategies in 2D monolayer cultures
either on extracellular matrices or stromal cell lines such as
PA6 cells (Cho et al., 2008, 2011; Kawasaki et al., 2000;
Schwartz et al., 2008). Some of the protocols include
application of soluble factors into the culture condition such
as sonic hedgehog (SHH), fibroblasts growth factor 8a (FGF8a),
SPIE factors (combination of four factors; stromal cell-derived
factor 1 (SDF-1), ephrin B1 (EFNB1); insulin-like growth factor
2 (IGF2); pleiotrophin (PTN)) (Vazin et al., 2009; Yamazoe et
al., 2005) and compound C (C) (Zhou et al., 2010).
Although many protocols have been published for differ-
entiating hESCs to the DA neurons, the research on scalable
and controlled culture systems is still needed before the
clinical application of hESCs becomes feasible (Kriks et al.,
2011). The limitations of existing protocols include low mdDA
neuronal generation efficiency and risk of contamination with
other cell types which may cause undesirable side effects
during transplantation (Wernig et al., 2008). Previous studies
have demonstrated that hESCs can be propagated and
differentiated under 3D environment involving alginate
microcapsules (Chayosumrit et al., 2010; Dean et al., 2006).
The entrapment of cells within alginate microcapsules allows
high-density cell culture and exchange of nutrients, oxygen
and stimuli across the membrane, whereas the cells are
protected from external threats such as antibodies from the
host (Dawson et al., 2008; Serra et al., 2011). It has been
shown that the alginate encapsulation technique promotes
better growth, differentiation, maturation or protein secre-
tion of various cell types including mesenchymal stem cells,
mouse ESCs and hESCs (Chayosumrit et al., 2010; Dean et al.,
2006; Serra et al., 2011; Addae et al., 2012). Despite the
success in many cell types, hESC differentiation studies using
alginate encapsulation are limited (Chayosumrit et al., 2010;
Addae et al., 2012; Bidarra et al., 2010; Raof et al., 2011; Fang
et al., 2007).
In this study, we present an approach to differentiate hESCs
to mdDA neurons in a 3D microenvironment using alginate
microcapsules on PA6 cell co-culture, alongwith SHH and FGF8a
as compared to that under 2D environment. To further optimize
the differentiation, the influence of supplementation with SPIE
factors and C to direct pluripotent hESCs to mdDA neurons was
also investigated. We have demonstrated a proof-of-principle
that the mdDA neurons can be obtained early from hESCs under
a 3D system compared to that under a 2D environment and
secrete more DA under potassium-induction.Materials and methods
Cell culture
The hESC lines, Endeavor-1, 2 (Sidhu and Tuch, 2006) and
MEL-1 (a gift from Monash University, Melbourne) were
cultured and maintained in a pluripotent state on
matrigel-coated (BD Sciences, California, US) culture plates
with mTeSR®1 media (STEMCELL Technologies, Vancouver,
CA). The culture medium was changed daily, with routinepassaging of hESCs every 5 to 6 days by using 1 mg/ml dispase
(STEMCELL Technologies, Vancouver, CA).
The mouse stromal cell line, PA6, was purchased from
Riken BioResource Center Cell Bank (Tsukuba, Japan, http://
www.brc.riken.jp/inf/en) and cultured in α-minimum essen-
tial media supplemented with 10% fetal bovine serum. The
medium was changed every other day, with routine passaging
of every 4 to 6 days by using trypsin (all from Invitrogen,
Camarillo, CA).
Encapsulation of hESCs
Encapsulation of hESCs was carried out as described earlier
from our laboratory (Chayosumrit et al., 2010; Dean et al.,
2006). Prior to encapsulation, hESCs were washed with
phosphate buffered saline (PBS; Invitrogen, Camarillo, CA)
twice and treated with 10 μM of Rho-associated protein kinase
inhibitor, also known as Y-27632 (RI; Merck, Darmstadt,
Germany), supplemented in mTeSR®1 media for 2 h. hESCs
were dissociated with accutase (Millipore, Temecula, CA) for
10 min and filtered through 40 μm cell strainers, followed by
washing with 0.9% saline. A mixture of 1.25 × 106 cells/ml in
1.1% purified sodium alginate (high glucuronic acid content
≥60%, viscosity N200 mPa s and endotoxin ≤100 EU/g)
(Pronova UP MVG, Novamatrix, Sandvika, Norway) was passed
through an air-driven droplet generator (Nisco Engineering
Inc., Zurich, Switzerland) at an air flow rate of 8 l/ml and a
pressure of 100 kPa as described (Chayosumrit et al., 2010).
The capsules were incubated in sterile 100 mM CaCl2/10 mM
HEPES (pH 7.4) for 7 min and washed twice with 0.9% saline
solution, followed by further treatment with 10 μM of RI in
mTeSR®1 media for 3 days prior to the differentiation.
DA neuronal differentiation under 3D environment
(encapsulation)
PA6 cells were seeded at 1.0 × 105 cells per cm2 in 0.1%
gelatin-coated T75 flask and the ratio between PA6 cells and
hESCs was 1.0 × 105 PA6 cells per 1.2 × 106 hESCs. After 24 h,
PA6 culture medium was replaced with differentiation
mediumwhich consists of Glasgowminimum essential medium
supplemented with 10% knockout serum replacement, 0.1 mM
non-essential amino acids, 1 mM sodium pyruvate and 0.1 mM
β-mercaptoethanol (all from Invitrogen, Camarillo, CA). The
RI-treated encapsulated hESCs were transferred to the PA6
cell culture flask to initiate differentiation on the next day.
The medium was changed on day 4 and every other day
thereafter. The hESCs were allowed to differentiate for
21 days, followed by supplementation with FGF8a (100 ng/ml)
and SHH (100 ng/ml) for additional 7 days (all from R&D
systems, Minneapolis, MN) (Fig. 1).
DA neuronal differentiation under 2D environment
To observe the difference of generatingmdDA neurons between
3D and conventional 2D differentiation systems, PA6 cell
co-culturing with cell culture insert differentiation protocol
was followed (Vazin et al., 2008). After pre-treatment with RI
for 2 h, the accutase treated single cells were filtered through
40 μm cell strainers. The cells were seeded at 3.0 × 106 cells
per well onto matrigel-coated 12-well cell culture plate,
Figure 1 Overview of DA neuronal differentiation. The dissociated RI-treated cells were either encapsulated or seeded onto
matrigel-coated dish and treated with RI for 3 days prior to differentiation. The prepared hESC were differentiated on PA6 cells or
with SPIE factors and/or C for 28 days.
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period of RI treatment, PA6 cells were seeded at 4.0 × 104 cells
per 12-well cell culture insert (Millipore, Temecula, CA). After
24 h, PA6 culture medium was replaced with differentiation
medium as described above. The medium of RI-treated hESCs
was replaced with PA6 cell conditioned-differentiation medium
along with the PA6 cells seeded cell culture inserts. The
differentiation was carried out for 21 days, followed by
supplementation of FGF8a (100 ng/ml) and SHH (100 ng/ml)
for additional 7 days in the same manner as in 3D differenti-
ation system (Fig. 1).
DA differentiation with SPIE factors and C
To further optimize the DA differentiation under 3D platform
protocol by increasing the rate of DA neuron production and
reducing the usage of xenogens, the effects of SPIE factors
(SDF-1; 100 ng/ml, PTN; 100 ng/ml, IGF2; 100 ng/ml, insulin-
like growth factor binding protein-4 (IGFBP4); 500 ng/ml, and
EFNB1; 200 ng/ml; all from R&D systems, Minneapolis, MN)
(Vazin et al., 2009) and C (10 μM;Merck Chemicals, Darmstadt,
Germany) (Zhou et al., 2010) were investigated. After the
encapsulation and post-treatment with RI as described from
above, the cells were cultured in differentiation media
supplemented with heparin (100 μg/ml; Sigma-Aldrich, St.
Louis, MO), and SPIE factors with or without C for 21 days. The
twomorphogens FGF8a (100 ng/ml) and SHH (100 ng/ml) were
supplemented in the differentiation media for additional
7 days in the same manner as in the 3D differentiation system
with the change of media every third day (Fig. 1).
Decapsulation of cells for further analysis
The alginate microcapsules can be depolymerized
(decapsulated) in the presence of a chelating agent
ethylenediaminetetraacetic acid (EDTA) (Chayosumrit et
al., 2010). Cells were retrieved from the capsules by
incubating in decapsulating solution (50 mM EDTA and
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid(HEPES) in PBS) for 4–5 min at room temperature.
Decapsulated cells were collected and analyzed for gene
and protein expression or cultured onto a matrigel-coated
culture plate with a density of approximately 1.0–2.0 × 105
cells per 10 cm2 for functional and immunofluorescent
staining analyses.Immunofluorescent staining
Expression of stem cell and neuronal markers was examined by
immunofluorescent staining. The cells were fixed with 4%
paraformaldehyde for 20 min, permeablized with 0.2% Triton
X-100 (all from Sigma-Aldrich, St. Louis, MO) in PBS for 10 min
and blocked with 10% donkey serum (Millipore, Temecula, CA)
in PBS for 1 h. The cells were then incubated with primary
antibodies overnight at 4 °C, followed by incubation with
appropriate secondary antibodies for 30–45 min at room
temperature. Nuclei were then stained using Prolong gold
antifade reagent with DAPI (Invitrogen, Camarillo, CA).
The primary antibodies used were as follows: rat anti-
octamer-4 (OCT4) (1:300, R&D systems, Minneapolis, MN),
rabbit anti-paired box gene-6 (PAX6) (1:50, Santa Cruz
Biotechnologies, Santa Cruz, CA), mouse anti-neurogenin-2
(NGN2) (1:100, R&D systems, Minneapolis, MN), mouse
anti-NESTIN (1:1000, Millipore, Temecula, CA), rabbit anti-
tubulin βIII (TUBB3) (1:1000, Covance, New Jersey, US), mouse
anti-nuclear related receptor-1 (NURR1) (1:100, Abnova,
Taipei, Taiwan), sheep anti-TH (1:100, Abcam, Cambridge,
England), goat anti-LIM LIM homeobox transcription factor 1, α
(LMX1A) (1:50, Santa Cruz Biotechnologies, Santa Cruz, CA),
mouse anti-FOXA2 (1:100, Abnova,Taipei, Taiwan) and
mouse anti-PITX3 (1:100, AbD Serotec, Kidlington, UK).
Secondary antibodies (1:500) used were: Alexa fluor® 488
donkey anti-rabbit IgG (H + L) antibody, Alexa fluor® 594
donkey anti-rabbit IgG (H + L) antibody, Alexa fluor® 488
donkey anti-goat IgG (H + L) antibody, Alexa fluor® 488 donkey
anti-mouse IgG (H + L) antibody, Alexa fluor® 594 donkey
anti-mouse IgG (H + L) antibody and Alexa fluor® 594 donkey
anti-sheep IgG (H + L) (all from Invitrogen, Camarillo, CA).
981Alginate microcapsule for the efficient differentiation of human embryonic stem cellsQuantitative polymerase chain reaction (PCR)
analysis
Total RNA was extracted from differentiated, undifferentiat-
ed hESCs and human fetal brain using Illustra RNAspin Mini Kit
(GE Healthcare, Piscataway, NJ). Standard reverse transcrip-
tion was performed using SuperScript III First-Strand Synthesis
System and Oligo (dT) primers (Invitrogen, Camarillo, CA).
Real-time PCR analysis was carried out on the CFX96
Real-Time PCR system using the SsoFast EvaGreen Supermix
(all from Biorad, Benecia, CA). The PCR reaction consisted of
5 μl of SsoFast EvaGreen Supermix, 0.5 μl of 500 nM forward
and reverse primers, 2.5 μl of milliQ water, and 2 μl of diluted
template cDNA (5 ng/reaction) in a total volume of 10 μl.
Initial enzyme activation was performed at 95 °C for 30 s,
followed by 40 cycles of denaturation at 95 °C for 5 s, and
primer annealing/extension at 60 °C for 10 s. Melting curve
analysis was performed at 65 °C for 5 s and 95 °C for plate
read. Relative fold changes were calculated using Pffafl's
calculations based on the ΔΔCt method (Pfaffl, 2001). All
genes of interest were normalized to the housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
samples were in general, relatively compared to a zero time
point or to control cell line, whichwas always set as 1 arbitrary
unit, unless, otherwise indicated.
Western blot analysis
The differentiated and non-differentiated hESCs were lysed
with radio immune precipitation assay (RIPA) buffer
supplemented with cocktail of protease inhibitor (all from
Sigma-Aldrich, St. Louis, MO). The proteins were purified by
centrifugal filter units (Millipore, Temecula, CA) and quanti-
fied by bicinchoninic acid (BCA) protein assay (Thermo Fisher,
Beverly, MA). 40 μg of protein was separated on a 10% precast
polyacrylamide gel (Biorad, Benecia, CA) at 90 V for 2 h and
transferred to a nitrocellulose membrane (Amersham Biosci-
ences, Sunnyvale, CA) at 300 mA for 45 min. The membrane
was blocked for 1 h and probed with primary antibodies for
overnight at 4 °C. This was followed by incubation with
appropriate secondary antibodies for 1 h at room temperature.
Western blotting detection reagents (Millipore, Temecula, CA)
were added to the membrane for 1 min. The membrane was
then exposed to the x-ray film (Radincon, Dee Why, Australia),
developed and fixed in the dark.
The primary antibodies used were rabbit anti-β-ACTIN
(1:5000, Santa Cruz Biotechnologies, Santa Cruz, CA), rabbit
anti-PAX6 (1:2000, Abcam, Cambridge, England) and rabbit
anti-TH (1:1000, Millipore, Temecula, CA). The secondary
antibody used was goat anti-rabbit IgG, (H + L) HRP conjugate
(1:3000, Millipore, Temecula, CA). The relative expression of
each protein was normalized against the housekeeping
protein, β-ACTIN. After normalization, samples were in
general, relatively compared to a zero time point or to control
cell line, which was always set as 1 arbitrary unit, unless,
otherwise indicated.
Enzyme-linked immunosorbent assay (ELISA) analysis
The decapsulated cells after seeding were analyzed for DA
secretion. The differentiating hESCs under 3D platform weredecapsulated at days 14 and 28. Similarly, the cells that
were differentiated in conventional 2D environment were
seeded at days 14 and 28. After 3–4 days, the medium was
removed and replaced with Ca2+ containing Hank's balanced
salt solution (Ca2+/HBSS; Invitrogen, Camarillo, CA) and
incubated at 37 °C for 10 min, followed by incubation with
56 mM KCl supplemented in Ca2+/HBSS at 37 °C for 30 min.
The cell culture supernatant was collected and stabilized
at a final concentration of 150 mM H3PO4 and 50 mM
diethylene–triamine–pentaacetate (DTPA). The sample
was immediately frozen in liquid nitrogen and stored at
−80 °C until assay. Prior to assay, the sample was thawed
and centrifuged at 16,700 ×g at 4 °C for 12 min. The
supernatant was collected and DA level was analyzed with
high-sensitive DA ELISA kit (Labor Diagnostika Nord,
Nordhorn, Germany). DA concentration was quantified by
comparison to known standard dilutions and well to well
variation was adjusted by counting the total number of
cells per well.
Statistical analyses
All differentiation experiments were performed in 3 inde-
pendent biological replicates for each hESC line, Endeav-
or-1, 2 and MEL-1. The data were obtained from technical
duplicates for each sample and significance was calculated
from the 3 biological replicates using Student's t-test in
Microsoft Excel, unless otherwise indicated; P-values were
b0.05 (⁎), 0.005 (⁎⁎), 0.0005 (⁎⁎⁎), and 0.00005 (⁎⁎⁎⁎). All
graph values were plotted as mean ± SEM using GraphPad
Prism 5 software.
Results
Encapsulation of hESCs as a 3D culture model
The diameter of alginate microcapsules remained 500 ±
100 μm with cell viability of N80 ± 5% when encapsulated
(Sidhu et al., 2012). The number of cells within the capsule
was estimated by calculating the total number of cells divided
by the total number of capsules per run, resulting in
approximately 5.0 × 104 cells per capsule (Sidhu et al.,
2012). To sustain the cell viability of encapsulated hESCs
prior to DA neuronal differentiation, the RI treatment of hESCs
before and briefly after encapsulation was employed and
found to be essential (Chayosumrit et al., 2010; Sidhu et al.,
2012). During the process of differentiation, the single cell
suspension within the capsules formed clusters or EBs with
gradual increase of its size (Fig. 2). A minimum number of
hESCs required for encapsulation were optimized to prevent
bursting of capsules.
Differentiation of encapsulated hESCs by co-culture
with PA6 cells
The microcapsules via encapsulation acted as a physical
barrier preventing direct contact between the differentiat-
ing hESCs and PA6 cells. To verify whether the spherical
shaped EBs express neuronal morphology and mdDA neuronal
markers, the EBs were decapsulated each week and seeded
Figure 2 Morphology of 3D and 2D differentiated hESCs with PA6 cells. Single-cell dissociated hESCs were encapsulated and
differentiated in 3D manner for 28 days (top panel). The differentiated cells under 3D system were decapsulated at each week,
seeded and cultured for 4 days prior to observation (middle panel). Similarly, the differentiated hESCs under 2D system were
collected, seeded and cultured on matrigel-coated culture plates for 4 days (bottom panel). Top panel scale bar = 200 μm. Middle
and bottom panel scale bar = 50 μm.
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seeded cells showed progressive neuronal differentiation
with extensive neurite formations (Fig. 3A). After 7 days of
differentiation, the cells were negative for pluripotent
markers; OCT4 and NANOG (data not shown) but positive
for NP marker; PAX6, and early neuronal marker; NESTIN
(Fig. 3A). At day 14, cells began to show more defined
neuron-like cells which expressed earlymdDA neuronalmarker;
NGN2 and mature neuronal marker; TUBB3 (Figs. 2 and 3A).
After 21 days, the cells were positive for mature DA neuronal
marker; TH which co-expressed early DA neuronal markers;
NURR1 and LMX1A. After 28 days of differentiation, TH+ cells
co-expressed late mdDA neuronal markers; FOXA2 and PITX3
(Fig. 3A). The percentage of TH+ cells after 28 days of
differentiation was estimated to be approximately 93 ± 3%
(Fig. 5B).
To study differential gene expressions during differentia-
tion, RNA samples were taken at certain time points and
analyzed by qPCR. The analysis showed down-regulation of
pluripotent marker; OCT4 after 7 days, while neuronal
markers; PAX6 (N1000 fold) and NGN2 (N1000 fold), TH
(N1000 fold) and LMX1B (N100 fold) were up-regulated after
7 days (Fig. 4A). However, 3D differentiated hESCs after
28 days showed lower TH and LMX1B gene expression levels
when compared to human fetal brain. Corresponding to these
data, western blot analysis showed up-regulation of PAX6 (N100
fold) at day 7, followed by down-regulation after day 14 whileTH (N100 fold) expression steadily up-regulated after day 7
(Fig. 4B).Comparison of derived DA neurons under 3D vs 2D
systems
To maintain the variability of indirect contact with PA6 cells
during differentiation, cell culture inserts were used. In
comparison to the 3D system, hESCs differentiated under the
2D system showed a slower progression towards neuronal
differentiation with less extensive neurite formations
(Fig. 2). The cells that were differentiated under the 2D
environment showed negative expressions for pluripotent
markers; OCT4 and NANOG (data not shown). However, the
neuronal markers; PAX6, NESTIN, NGN2 and TUBB3 at day 7
were also negative but only showed the expressions after
day 14 (Fig. 3). After 28 days, the cells were positive for TH
(approximately 52 ± 5%) and co-expressed NURR1 and LMX1A
(Fig. 3B). Interestingly, the TH+ cells co-expressed FOXA2
and PITX3 after extended 35 days of differentiation
(Fig. 3B).
In correspondence to the data, qPCR analysis showed lower
level of expressions in all of the neuronal markers above in
comparison to differentiated cells under 3D platform and
human fetal brain, particularly TH level, which showed
significant (P b 0.05) difference between the two systems
Figure 3 Immunofluorescent analysis of 3D + PA6 vs 2D + PA6. The cells that were differentiated under 3D platform with PA6 cells
were decapsulated, seeded and cultured on matrigel-coated culture plates for 4 days prior to analysis (A). Similarly, hESC under 2D
manner with PA6 cells were collected, seeded and cultured on matrigel-coated cultured plates for 4 days prior to analysis (B). The
images represent the onset of DA neuronal markers. Scale bar = 50 μm.
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expression level was significantly (P b 0.05) much lower than
that observed under the 3D platform while maintaining a
significantly (P b 0.05) higher level of PAX6 expression from
days 14 to 28 (Fig. 4B).
The direct comparison of gene and protein expression
analyses revealed that the differentiated hESCs under the 3D
environment expressed the mature DA neuronal markers
earlier than the cells that were cultured under the 2D system
(Figs. 4A and B). In addition to this, the 3D system promoted
down-regulation trend of PAX6 after 7 days, while the hESCs
under the 2D environment maintained high expression level
after 14 days (Fig. 4B). This indicates that the 3D differenti-
ation system has the capacity to drive the pluripotent hESCs to
mature neuronal lineage faster than the cells under the 2D
environment that has a slower rate of differentiating the cells
into mature neurons. Concurrent with these data, TH marker
was highly expressed in hESCs under the 3D environment thanthe 2D system throughout the differentiation process (N100
fold after 2 weeks) (Fig. 4A). Also, we have shown that the 3D
differentiated cells depicted higher expression of early and
late mdDA neuronal markers; NGN2, LMX1B, in comparison to
the 2D environment (Fig. 4A).Further optimization of 3D system for future
therapeutics under feeder-free environment
To further optimize the 3D differentiation protocol by
increasing the production of DA neurons and reducing the
usage of xenogens in the culture system, PA6 cells were
replaced with SPIE factors and with or without C. After
7 days of differentiation, the decapsulated and seeded cells
showed distinctive neuronal morphology which is an early
stage of differentiation. Similarly with hESCs differentiated
under 3D platform with PA6 cells, both samples were
Figure 4 Gene and protein expression analysis of 3D + PA6 vs 2D + PA6. RNA samples of 3D + PA6 vs 2D + PA6 (A) were isolated at different time points for qPCR analysis (including
RNA sample from human fetal brain as a positive control). Protein samples of 3D + PA6 vs 2D + PA6 (B) were isolated at different time points for western blot analysis, showing
immunoblot bands and their representative graphs. Data presented as mean ± S.D. (biological replicates = 3 of each hESC line), Student's t-test, unpaired, two-tailed. The results
were considered significant when P-values were b0.05 (⁎), 0.005 (⁎⁎), 0.0005 (⁎⁎⁎), and 0.00005 (⁎⁎⁎⁎). Abbreviation — HFBrain: human fetal brain.
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Figure 5 Immunofluorescent analysis of 3D + SPIE vs 3D + SPIE + C and estimated TH + cells of differentiated hESCs. The cells that were differentiated under 3D platform with SPIE
with/without C were decapsulated, seeded and cultured on matrigel-coated culture plates for 4 days prior to analysis (A). Total of 300 cells of each differently differentiated hESC
were counted at weekly points, estimated the average percentage of TH+ cells (B). The images represent the onset of DA neuronal markers. Scale bar = 50 μm. Data presented as
mean ± S.D. (biological replicates = 3 of each hESC line), Student's t-test, unpaired, two-tailed. The results were considered significant when P-values were b0.05 (⁎), 0.005 (⁎⁎),
0.0005 (⁎⁎⁎), and 0.00005 (⁎⁎⁎⁎).
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Figure 6 Gene and protein expression analysis of 3D + SPIE vs 3D + SPIE + C. RNA samples of 3D + SPIE vs 3D + SPIE + C (A) were isolated at different time points for qPCR analysis
(including RNA sample from human fetal brain as a positive control). Protein samples of 3D + SPIE vs 3D + SPIE + C (B) were isolated at different time points for western blot analysis,
showing immunoblot bands and their representative graphs. Data presented as mean ± S.D. (biological replicates = 3 of each hESC line), Student's t-test, unpaired, two-tailed. The
results were considered significant when P-values were b0.05 (⁎), 0.005 (⁎⁎), 0.0005 (⁎⁎⁎), and 0.00005 (⁎⁎⁎⁎). Abbreviation — HFBrain: human fetal brain.
986
J.
Kim
et
al.
987Alginate microcapsule for the efficient differentiation of human embryonic stem cellsnegative for OCT4 and NANOG (data not shown) but positive
for PAX6 and NESTIN at day 7, followed by co-expression of
NGN2 and TUBB3 after day 14. After 21 days of differenti-
ation, TH+ cells co-expressed NURR1 and LMX1A, followed by
co-expression of FOXA2 and PITX3 after 28 days (Fig. 5A).
After 28 days of differentiation, both SPIE and SPIE + C
samples showed approximately 91 ± 3% and 92 ± 4% TH
positive expression, respectively (Fig. 5B).
To investigate whether the gene expression analysis will
show any differences, qPCR was conducted. The data showed
similar expression levels of neuronal markers with no
significant difference between the two treatments and lower
TH and LMX1B gene expression levels than human fetal brain
(Fig. 6A). Western blot analysis showed down-regulation of
PAX6 expression after day 7 while TH expression showed
steady up-regulation throughout the differentiation (Fig. 6B).
However, there were no significant differences between the
two treatments.
To observe the rate of DA neuronal differentiation from the
four different systems, the expression levels of neuronal
markers at each end point were directly compared. The hESCs
that were differentiated in a conventional 2D protocol showed
significantly higher PAX6 expression after 28 days (Fig. 7).
However, the hESCs under the 3D platform, SPIE and SPIE + C
differentiated hESCs showed higher expression of other
mature neuronal markers compared to the 2D differentiation
system (Fig. 7). The data suggested that the combination of
co-culturing with PA6 cells via microencapsulation allows the
pluripotent hESCs to mature mdDA neurons faster than the
other systems within 28 days of differentiation.Figure 7 Expression level comparison at each end point. Graph of qP
fetal brain as a positive control) (A). Graph of western blot analysis at
presented as mean ± S.D. (biological replicates = 3 of each hESC line),
significant when P-values were b0.05 (⁎), 0.005 (⁎⁎), 0.0005 (⁎⁎⁎), and 0Functional analysis of DA neurons obtained under
3D and 2D platforms
The differentiated cells under 3D and 2D PA6 co-culturing
systems were analyzed for DA secretion under KCl-induction
in vitro using high-sensitive DA ELISA assay. Overall, the cells
that were not induced with KCl had much lower DA level in
the supernatant than the samples with KCl-induced (Fig. 8).
The direct comparison of DA secretion levels between
KCl-induced samples showed significantly (P b 0.05) higher
DA level in cells under the 3D platform in both days 14 and
28, particularly day 28 samples of cells under the 3D system
resulted in N4 fold higher DA level than cells differentiated
for 28 days in the 2D platform (Fig. 8). The data from ELISA
correlate with the above gene and protein expression data
indicating there are higher numbers of functionally active DA
neurons when differentiated under the 3D environment than
the conventional 2D system.
Discussion
Microcapsules and microcarriers have been used in many
studies as 3D culture systems to grow and differentiate stem
cells despite their potential application for neuronal differen-
tiation (Dawson et al., 2008; Fang et al., 2007; Sidhu et al.,
2012). In this study, a novel protocol has been established
that involves 3D differentiation strategies using alginate
microcapsules. The advantage of this method is that it is a
single step process and physically separates the differentiatingCR analysis at day 28 of differently treated hESCs (including human
day 28 of differentiated hESCs under different conditions (B). Data
Student's t-test, unpaired, two-tailed. The results were considered
.00005 (⁎⁎⁎⁎). Abbreviation — HFBrain: human fetal brain.
Figure 8 DA secretion analysis using ELISA. After 14 and 28 days
of differentiation, the cells that were differentiated under 3D or
2D environment with PA6 cells were collected and seeded onto
matrigel-coated culture dish. After 4 days, the cell culture
supernatants were collected which were incubated in Ca2+/HBSS
and followed by 56 mM KCl supplemented in Ca2+/HBSS. Data
presented as mean ± S.D. (biological replicates = 3 of each hESC
line), Student's t-test, unpaired, two-tailed. The results were
considered significant when P-values were b0.05 (⁎), 0.005 (⁎⁎),
0.0005 (⁎⁎⁎), and 0.00005 (⁎⁎⁎⁎).
988 J. Kim et al.hESCs, thus avoiding the necessary enzymatic digestion of PA6
cells to isolate the differentiated cells. Furthermore, the 3D
strategy to derive DA neurons has shown to produce faster
expression of TH+ neurons which also secretes higher level of
DA when induced compared to the conventional 2D protocol
after 28 days of differentiation. However, it must be noted
that the percentage data of TH+ neurons from this study are
still estimation and require further verification by FACS.
The optimized encapsulation protocol from above allows
for single hESC to survive, proliferate and form aggregates
within the microcapsules in the presence of RI. The chemical
compound has been shown to inhibit cell apoptosis, resulting
in N80 ± 5% hESC viability inside a capsule diameter size of
500 ± 100 μm as reported previously (Chayosumrit et al.,
2010; Sidhu et al., 2012). The encapsulated cells can be
released via decapsulation process and cultured as a mono-
layer on matrigel-coated culture plates. The cells were
seeded at a density of approximately 1.0–2.0 × 105 cells
per 10 cm2 which had the viability of 95 ± 1% (Sidhu et al.,
2012).
The data further demonstrated that the encapsulated
hESCs can be differentiated into mdDA neurons after 28 days
as a 3Dmodel environment. The starting number of hESCs that
can be encapsulated with minimum risk of EB overgrowth and
capsule breakage were optimized prior to differentiation. It is
crucial to note that throughout the differentiation process,
the number and size of EB increases (approximately 10–20 EB
per capsule with 50–200 μm in diameter per EB) which may
limit the diffusion of growth factors and gas substrates within
aggregates (Yi et al., 2010). However, the low oxygen/hypoxic
environment within the EB may have increased the rate of DA
neuronal expressions which has been previously reported that
the cells in hypoxic culture condition enhance the DA neuronal
differentiation (Francis and Wei, 2010). In addition, it has
been shown that cells cultured in a 3D environment can freely
interact with neighboring cells in a 3D environment and
respondmore readily to each other, which significantly affects
stem cell fate decisions such as apoptosis, self-renewal and
differentiation (Yi et al., 2010). In comparison to the cell–cellinteraction and the hypoxic environment of EB, the conven-
tional 2D differentiation system has limited cell–cell contact
with its neighbor cells and higher exposure to oxygenmay have
led to slower mdDA neuronal expressions than differentiated
hESCs under 3D environment. However, the comparison of DA
neuronal gene expression levels of 3D differentiated hESCs
after 28 days against human fetal brain suggests that the cells
differentiated in 3D manner are early DA neurons and may
require to be differentiated for longer period of time to
become fully mature DA neurons.
In order to allow the transition of hESCs to clinical
application, it is essential that the culture system is
xeno-free to eliminate any harmful effect it may cause to
patients. Therefore, the 3D differentiation platform with
PA6 cells is needed to be modified as the culture system
contains several xenogens such as mouse-derived PA6 cells,
FBS supplementation and xeno-derived trypsin. The appli-
cation of human-derived SPIE and a chemical compound, C
helps to limit the usage of xenogens. The data demonstrated
that the differentiation in the 3D environment with SPIE
factors can produce approximately N90% TH+ neurons after
28 days, showing faster rate of TH+ neuronal expression than
the conventional 2D differentiation with SPIE factors which
produces approximately 50% DA neurons after 28 days (Vazin
et al., 2009). However, it is suspected that there are still
necessary factors other than SPIE yet to be investigated
which assist in mdDA neuronal differentiation (Vazin et al.,
2009). The inhibitor C showed no significant further
improvement on differentiating hESCs to DA neuronal
lineage when used in conjunction with SPIE. However, the
effectiveness of using C alone in a 3D environment to derive
DA neurons could be an interesting approach which could
potentially be investigated in the future. Although the
presence of xenogens in the culture is limited, the necessary
supplementation of RI to maintain the viability of encapsu-
lated hESCs or the C for DA neuronal differentiation may
cause concerns as the long-term effect of the chemical
compounds to human is still unknown.
The functional in vitro data using high-sensitive ELISA
suggested that the 3D model-derived TH+ neurons secrete DA
at a higher level than hESCs derived from the conventional
2D platform upon K+ induction. However, it is recommended
that the ELISA data be validated via high performance liquid
chromatography (HPLC) assay in the future. Also, further
functional analysis is required such as electrophysiology
using whole cell patch clamp in order to fully characterize
the differentiated cells.Conclusions
In conclusion, the experiments herein demonstrated and
provided as a proof-of-principle that 3D differentiation via
microencapsulation is a powerful tool for DA neuronal
differentiation. However, further analyses by differentiating
the neurons under 3D and 2D platforms for longer period,
followed by characterization of these cells using electro-
physiology and transplantation assay in Parkinsonian rat
model are required. Generating robust functional DA
neurons efficiently is an essential requirement if cell
therapy for PD is to become a reality. The study's proposed
3D platform is an effort in that direction.
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